- Home
- GTBP vs PAVM Comparison
GTBP vs PAVM Comparison
Compare GTBP & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- PAVM
- Stock Information
- Founded
- GTBP 1965
- PAVM 2014
- Country
- GTBP United States
- PAVM United States
- Employees
- GTBP N/A
- PAVM N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- GTBP Health Care
- PAVM Health Care
- Exchange
- GTBP Nasdaq
- PAVM Nasdaq
- Market Cap
- GTBP 6.8M
- PAVM 7.2M
- IPO Year
- GTBP N/A
- PAVM 2016
- Fundamental
- Price
- GTBP $2.25
- PAVM $0.65
- Analyst Decision
- GTBP Strong Buy
- PAVM Strong Buy
- Analyst Count
- GTBP 1
- PAVM 1
- Target Price
- GTBP $11.00
- PAVM $19.00
- AVG Volume (30 Days)
- GTBP 244.8K
- PAVM 210.8K
- Earning Date
- GTBP 03-25-2025
- PAVM 03-25-2025
- Dividend Yield
- GTBP N/A
- PAVM N/A
- EPS Growth
- GTBP N/A
- PAVM N/A
- EPS
- GTBP N/A
- PAVM 0.53
- Revenue
- GTBP N/A
- PAVM $4,034,000.00
- Revenue This Year
- GTBP N/A
- PAVM $52.90
- Revenue Next Year
- GTBP N/A
- PAVM $248.84
- P/E Ratio
- GTBP N/A
- PAVM $1.23
- Revenue Growth
- GTBP N/A
- PAVM 166.27
- 52 Week Low
- GTBP $1.72
- PAVM $0.57
- 52 Week High
- GTBP $10.66
- PAVM $3.50
- Technical
- Relative Strength Index (RSI)
- GTBP 44.16
- PAVM 45.41
- Support Level
- GTBP $2.01
- PAVM $0.62
- Resistance Level
- GTBP $2.27
- PAVM $0.70
- Average True Range (ATR)
- GTBP 0.22
- PAVM 0.05
- MACD
- GTBP -0.01
- PAVM 0.01
- Stochastic Oscillator
- GTBP 38.71
- PAVM 61.20
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.